Showing results (631-640 of 670) with videos related to

Sort By:
Pageof 67
Msphere|July 3, 2020
Increasing Temperature and Relative Humidity Accelerates Inactivation of SARS-CoV-2 on SurfacesJennifer Biryukov, Jeremy A Boydston, Rebecca A Dunning, et al.
International Journal of Radiation Oncology, Biology, Physics|May 25, 2020
Bridging Radiation Therapy Before Commercial Chimeric Antigen Receptor T-Cell Therapy for Relapsed or Refractory Aggressive B-Cell LymphomaChristopher M Wright, Michael J LaRiviere, Jonathan A Baron, et al.
Plos One|October 11, 2012
qpure: A tool to estimate tumor cellularity from genome-wide single-nucleotide polymorphism profilesSarah Song, Katia Nones, David Miller, et al.
Nucleic Acids Research|November 19, 2011
InterPro in 2011: new developments in the family and domain prediction databaseSarah Hunter, Philip Jones, Alex Mitchell, et al.
Regulatory Toxicology and Pharmacology : RTP|October 31, 2021
Opportunities and challenges related to saturation of toxicokinetic processes: Implications for risk assessmentYu-Mei Tan, Hugh A Barton, Alan Boobis, et al.
Current Environmental Health Reports|August 2, 2015
MDI Biological Laboratory Arsenic Summit: Approaches to Limiting Human Exposure to ArsenicBruce A Stanton, Kathleen Caldwell, Clare Bates Congdon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
The Potent ALK Inhibitor Brigatinib (AP26113) Overcomes Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in Preclinical ModelsSen Zhang, Rana Anjum, Rachel Squillace, et al.
International Journal of Radiation Oncology, Biology, Physics|July 25, 2022
A Phase I Trial of Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for Locally Advanced Prostate CancerLiat Hammer, Ralph Jiang, Jason Hearn, et al.
Journal of Medicinal Chemistry|November 25, 2024
Novel Macrocyclic NLRP3 InhibitorsStefanie Mesch, Jonathan Shannon, David Miller, et al.
Pageof 67